Profile

Nathan Edward Millard, MD

Nathan Edward Millard, MD

Hematology-Oncology

On staff since May 2018

    • Becher OJ, Millard NE, Modak S, Kushner BH, Haque S, Spasojevic I, Trippett TM, Gilheeney SW, Khakoo Y, Lyden DC, De Braganca KC, Kolesar JM, Huse JT, Kramer K, Cheung NV, Dunkel IJ
      A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
      28582410 PloS one , 2017 : 12(6)e0178593 PMCID: PMC5459446
    • Millard NE, De Braganca KC
      Medulloblastoma.
      26336203 Journal of child neurology , 2016 Oct. : 31(12)1341-53 PMCID: PMC4995146
    • Millard NE, Dunkel IJ
      Advances in the management of central nervous system germ cell tumors.
      24838613 Current oncology reports , 2014 July : 16(7)393

Overview

Board Certification(s)

Pediatrics

Medical/Professional School

George Washington University, Washington

Residency

Pediatrics, Boston Children's Hospital, Boston

Fellowship

Pediatric Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York
Pediatric Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York